Ongoing controversy over the optimal approach to breast cancer screening has led to discordant
professional society recommendations, particularly in women age 40 to 49 years. One …

Breast cancer risk assessment can inform the use of screening and prevention modalities.
We investigated the performance of the Breast Cancer Surveillance Consortium (BCSC) risk …

Breast cancer risk reduction has been validated by large-scale clinical trials, but uptake remains
low. A risk communication tool could provide personalized risk-reduction information for …

After 20 years of screening for breast and prostate cancer, several observations can be made.
First, the incidence of these cancers increased after the introduction of screening but has …

Several important lessons have been learnt from our experiences in screening for various
cancers. Screening programmes for cervical and colorectal cancers have had the greatest …

The significant increase in the detection and treatment of ductal carcinoma in situ (DCIS)
since the introduction of screening mammography has not been accompanied by the …

We sought to compare the molecular signature of node negative cancers from two cohorts 15
years apart, to determine if there is molecular evidence of increase in low and ultralow risk …

Background More than 180 single nucleotide polymorphisms (SNPs) associated with breast
cancer susceptibility have been identified; these SNPs can be combined into polygenic risk …

Background Obesity and elevated breast density are common risk factors for breast cancer,
and their effects may vary by estrogen receptor (ER) subtype. However, their joint effects on …

… Author links open overlay panel Yiwey Shieh MD a , Martin … Shieh, M. Eklund, GF
Sawaya, WC Black, BS Kramer, LJ … Drs Shieh and Bohnenkamp contributed equally to this …